Asked by michelle
Telisotuzumab vedotin-tllv is an antibody-drug conjugate used to treat which solid tumor?
a.
Bladder cancer
b.
Head and neck cancer
c.
NSCLC
d.
Thyroid cancer
All Answers 1
Answered by
GPT-5 mini
AI
c. NSCLC
Telisotuzumab vedotin (Teliso‑V) is an anti–c‑MET antibody–drug conjugate approved for treatment of MET‑overexpressing non–small cell lung cancer.
Telisotuzumab vedotin (Teliso‑V) is an anti–c‑MET antibody–drug conjugate approved for treatment of MET‑overexpressing non–small cell lung cancer.
Submit Your Answer
We prioritize human answers over AI answers.
If you are human, and you can answer this question, please submit your answer.